140 related articles for article (PubMed ID: 24398967)
1. MicroRNA-301b promotes cell invasiveness through targeting TP63 in pancreatic carcinoma cells.
Funamizu N; Lacy CR; Parpart ST; Takai A; Hiyoshi Y; Yanaga K
Int J Oncol; 2014 Mar; 44(3):725-34. PubMed ID: 24398967
[TBL] [Abstract][Full Text] [Related]
2. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer.
Li P; Xing W; Xu J; Yuan D; Liang G; Liu B; Ma H
Stem Cell Res Ther; 2019 May; 10(1):144. PubMed ID: 31113460
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of miR-210 involved in epithelial-mesenchymal transition of pancreatic cancer cells under hypoxia.
Ni J; Zhou S; Yuan W; Cen F; Yan Q
J Recept Signal Transduct Res; 2019; 39(5-6):399-406. PubMed ID: 31875764
[No Abstract] [Full Text] [Related]
4. A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2.
Yang S; He P; Wang J; Schetter A; Tang W; Funamizu N; Yanaga K; Uwagawa T; Satoskar AR; Gaedcke J; Bernhardt M; Ghadimi BM; Gaida MM; Bergmann F; Werner J; Ried T; Hanna N; Alexander HR; Hussain SP
Cancer Res; 2016 Jul; 76(13):3838-50. PubMed ID: 27197190
[TBL] [Abstract][Full Text] [Related]
5. Involvement of microRNA-181b in the gemcitabine resistance of pancreatic cancer cells.
Takiuchi D; Eguchi H; Nagano H; Iwagami Y; Tomimaru Y; Wada H; Kawamoto K; Kobayashi S; Marubashi S; Tanemura M; Mori M; Doki Y
Pancreatology; 2013; 13(5):517-23. PubMed ID: 24075517
[TBL] [Abstract][Full Text] [Related]
6. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
[TBL] [Abstract][Full Text] [Related]
7. MIR-301b-3p Promotes Lung Adenocarcinoma Cell Proliferation, Migration and Invasion by Targeting DLC1.
Liu H; Ma X; Niu N; Zhao J; Lu C; Yang F; Qi W
Technol Cancer Res Treat; 2021; 20():1533033821990036. PubMed ID: 33754907
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance.
Moriyama T; Ohuchida K; Mizumoto K; Yu J; Sato N; Nabae T; Takahata S; Toma H; Nagai E; Tanaka M
Mol Cancer Ther; 2009 May; 8(5):1067-74. PubMed ID: 19435867
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-301b promotes the proliferation and invasion of glioma cells through enhancing activation of Wnt/β-catenin signaling via targeting Glypican-5.
Hong X; Zhang Z; Pan L; Ma W; Zhai X; Gu C; Zhang Y; Bi X; Huang W; Pei H; Liu Z
Eur J Pharmacol; 2019 Jul; 854():39-47. PubMed ID: 30951720
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia induced microRNA-301b-3p overexpression promotes proliferation, migration and invasion of prostate cancer cells by targeting LRP1B.
Zheng H; Bai L
Exp Mol Pathol; 2019 Dec; 111():104301. PubMed ID: 31442444
[TBL] [Abstract][Full Text] [Related]
11. microRNA-497 prevents pancreatic cancer stem cell gemcitabine resistance, migration, and invasion by directly targeting nuclear factor kappa B 1.
Yu Q; Xiu Z; Jian Y; Zhou J; Chen X; Chen X; Chen C; Chen H; Yang S; Yin L; Zeng W
Aging (Albany NY); 2022 Jul; 14(14):5908-5924. PubMed ID: 35896012
[TBL] [Abstract][Full Text] [Related]
12. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI
Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD.
Song H; Li D; Wu T; Xie D; Hua K; Hu J; Deng X; Ji C; Deng Y; Fang L
BMB Rep; 2018 Nov; 51(11):602-607. PubMed ID: 30269739
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-1469-5p promotes the invasion and proliferation of pancreatic cancer cells via direct regulating the NDRG1/NF-κB/E-cadherin axis.
Liu J; Zhu C; Zhang L; Lu H; Wang Z; Lv J; Fan C
Hum Cell; 2020 Oct; 33(4):1176-1185. PubMed ID: 32757096
[TBL] [Abstract][Full Text] [Related]
15. Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells.
Shen Y; Pan Y; Xu L; Chen L; Liu L; Chen H; Chen Z; Meng Z
Tumour Biol; 2015 Jun; 36(6):4525-34. PubMed ID: 25722110
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells.
Ma C; Huang T; Ding YC; Yu W; Wang Q; Meng B; Luo SX
Int J Clin Exp Pathol; 2015; 8(6):6533-9. PubMed ID: 26261532
[TBL] [Abstract][Full Text] [Related]
17. miR-203 promotes proliferation, migration and invasion by degrading SIK1 in pancreatic cancer.
Ren ZG; Dong SX; Han P; Qi J
Oncol Rep; 2016 Mar; 35(3):1365-74. PubMed ID: 26719072
[TBL] [Abstract][Full Text] [Related]
18. MiR-21 upregulation induced by promoter zone histone acetylation is associated with chemoresistance to gemcitabine and enhanced malignancy of pancreatic cancer cells.
Song WF; Wang L; Huang WY; Cai X; Cui JJ; Wang LW
Asian Pac J Cancer Prev; 2013; 14(12):7529-36. PubMed ID: 24460329
[TBL] [Abstract][Full Text] [Related]
19. MGMT expression affects the gemcitabine resistance of pancreatic cancer cells.
Shi Y; Wang Y; Qian J; Yan X; Han Y; Yao N; Ma J
Life Sci; 2020 Oct; 259():118148. PubMed ID: 32721465
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer.
Fan P; Liu L; Yin Y; Zhao Z; Zhang Y; Amponsah PS; Xiao X; Bauer N; Abukiwan A; Nwaeburu CC; Gladkich J; Gao C; Schemmer P; Gross W; Herr I
Cancer Lett; 2016 Apr; 373(1):130-137. PubMed ID: 26828016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]